Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2007
A new multi-clade DNA prime/recombinant MVA boost vaccine induces broad and high levels of HIV-1-specific CD8(+) T-cell and humoral responses in miceAndreas Bråve, Andreas Boberg, Lindvi Gudmundsdotter, et al.Plos One|October 25, 2011
Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trialsLycias Zembe, Wendy A Burgers, Heather B Jaspan, et al.Vaccine|March 9, 2005
Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in ThailandChitraporn Karnasuta, Robert M Paris, Josephine H Cox, et al.Human Immunology|June 29, 2004
HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected EthiopiansGuido Ferrari, Jeffrey R Currier, Matthew E Harris, et al.Journal of Immunological Methods|December 3, 2013
Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responsesMarloes A Naarding, Natalia Fernandez, John C Kappes, et al.The Journal of Infectious Diseases|August 14, 2016
A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative MenStuart P Adler, Anne-Marie Manganello, Ronzo Lee, et al.Plos One|September 28, 2011
A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cellsMichael A Eller, Bonnie M Slike, Josephine H Cox, et al.Clinical and Vaccine Immunology : CVI|March 5, 2010
Quality monitoring of HIV-1-infected and uninfected peripheral blood mononuclear cell samples in a resource-limited settingRobert E Olemukan, Leigh Anne Eller, Benson J Ouma, et al.African Journal of Laboratory Medicine|April 9, 2021
Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trialsRobert K Langat, Bashir Farah, Jackton Indangasi, et al.Clinical Immunology (Orlando, Fla.)|June 9, 2004
Immune reconstitution following autologous transfers of CD3/CD28 stimulated CD4(+) T cells to HIV-infected personsWendy B Bernstein, Josephine H Cox, Naomi E Aronson, et al.Pageof 6